Compugen Ltd. (CGEN)
2.13
+0.01
(+0.47%)
USD |
NASDAQ |
Oct 09, 16:00
2.13
0.00 (0.00%)
After-Hours: 20:00
Compugen Price : 2.13 for Oct. 9, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 09, 2026 | 2.13 | 2.13 | 2.08 | 2.13 | 123364.0 |
| Oct 08, 2026 | 2.14 | 2.16 | 2.04 | 2.12 | 243152.0 |
| Oct 07, 2026 | 2.22 | 2.225 | 2.13 | 2.15 | 201813.0 |
| Oct 06, 2026 | 2.32 | 2.331 | 2.205 | 2.22 | 265380.0 |
| Oct 05, 2026 | 2.30 | 2.32 | 2.25 | 2.31 | 198865.0 |
| Oct 02, 2026 | 2.34 | 2.38 | 2.305 | 2.31 | 113986.0 |
| Oct 01, 2026 | 2.39 | 2.435 | 2.33 | 2.34 | 173347.0 |
| Sep 30, 2026 | 2.35 | 2.41 | 2.345 | 2.38 | 118237.0 |
| Sep 29, 2026 | 2.32 | 2.35 | 2.30 | 2.35 | 117183.0 |
| Sep 28, 2026 | 2.34 | 2.345 | 2.315 | 2.33 | 94072.00 |
| Sep 25, 2026 | 2.40 | 2.42 | 2.345 | 2.38 | 77757.00 |
| Sep 24, 2026 | 2.34 | 2.375 | 2.325 | 2.37 | 111365.0 |
| Sep 23, 2026 | 2.45 | 2.47 | 2.305 | 2.34 | 288332.0 |
| Sep 22, 2026 | 2.46 | 2.495 | 2.405 | 2.49 | 230978.0 |
| Sep 21, 2026 | 2.45 | 2.495 | 2.42 | 2.435 | 217394.0 |
| Sep 18, 2026 | 2.47 | 2.49 | 2.45 | 2.49 | 128001.0 |
| Sep 17, 2026 | 2.42 | 2.47 | 2.42 | 2.46 | 122757.0 |
| Sep 16, 2026 | 2.41 | 2.47 | 2.40 | 2.41 | 117642.0 |
| Sep 15, 2026 | 2.49 | 2.49 | 2.37 | 2.41 | 330761.0 |
| Sep 14, 2026 | 2.42 | 2.54 | 2.42 | 2.48 | 144471.0 |
| Sep 11, 2026 | 2.47 | 2.496 | 2.43 | 2.47 | 162163.0 |
| Sep 10, 2026 | 2.48 | 2.51 | 2.44 | 2.46 | 206983.0 |
| Sep 09, 2026 | 2.55 | 2.55 | 2.46 | 2.48 | 293783.0 |
| Sep 08, 2026 | 2.55 | 2.625 | 2.55 | 2.56 | 192901.0 |
| Sep 04, 2026 | 2.54 | 2.61 | 2.54 | 2.59 | 199695.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Pluri, Inc. | 0.9532 |
| Evogene Ltd. | 0.3822 |
| Scinai Immunotherapeutics Ltd. | 1.18 |
| CollPlant Biotechnologies Ltd. | 3.51 |
| Regentis Biomaterials Ltd. | 1.60 |
Price Related Metrics
| PE Ratio | 5.749 |
| PS Ratio | 2.716 |
| Price to Book Value | 2.274 |
| Earnings Yield | 17.39% |
| Market Cap | 201.76M |
| Operating PE Ratio | 6.634 |
| Normalized PE Ratio | 5.750 |